ArticleScientific reports2025
Enhancing breast cancer diagnosis through machine learning algorithms.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Advancements in Machine Learning-Assisted Flexible Electronics: Technologies, Applications, and Future Prospects.Biosensors · 2026Pooled it
- Leveraging time-series electronic health records with large language models for chronic kidney disease diagnosis in primary care.BMJ health & care informatics · 2026Article
- MRI quantification of intratumoral heterogeneity for predicting HER2-positive status in breast cancer: a retrospective multicenter study.BMC cancer · 2026Article
- Review
- Integrated multi-omics identifies MCRS1 as a causal hub linking aging, metabolic syndrome, and breast cancer progression.International journal of surgery (London, England) · 2026Article
- Artificial intelligence for triple-negative breast cancer from imaging to multi-omics.Frontiers in oncology · 2026Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Among the most important health concerns in the world, and the number one cause of death in women, is breast cancer. Bearing in mind that there are more than 100 types of cancer, each presenting different symptoms, its early detection is indeed a big challenge. The prevalence of breast cancer indicates the prudent need for effective diagnostic and prognostic approaches. From 2016 to 2020, 19.6 deaths per 100, 000 women occurred annually due to breast cancer-a factor indicating the importance of early treatments. Machine Learning has become important for the improvement of early diagnosis and prognosis that may have the potential to reduce mortality rates. Some considerable volume of research work has been carried out on the use of Machine Learning algorithms for accurate diagnosis of breast cancer. In this research has done extensive algorithm evaluation like SVM, DT, RF, Logistic regression, KNN and ANN using datasets CDP Breast Cancer. The important performance indicators observed for each of these algorithms included accuracy, precision, recall, sensitivity, and specificity. These findings are an important step forward in the application of Machine Learning to improve diagnostic accuracy, thus enabling early detection and mitigating the major consequences of breast cancer on global health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.